Norditropin Injection, Solution
Product Images NDC 0169-7705

Product Visual Gallery

This gallery contains 100 technical images submitted to the FDA as part of the official labeling for Norditropin (NDC 0169-7705). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Important 5 (Export 00)

Norditropin 5 mg/1.5 mL subcutaneous injection solution carton and vial label. The packaging includes the brand name Norditropin, generic name somatropin, strength (5 mg per 1.5 mL), and the Novo Nordisk labeler. The vial is clear with a green cap and contains solution for injection.*

FDA Label Image

W5 (Export 01)

Norditropin 10 mg/1.5 mL injection solution vial label. The label includes the brand name Norditropin and generic name somatropin. It indicates that the solution is for subcutaneous use and shows dosage strength of 10 mg per 1.5 mL. The labeler is Novo Nordisk. The vial is clear with a pale pink cap.*

FDA Label Image

W5 (Export 02)

Norditropin 15 mg/1.5 mL injection solution package label for subcutaneous use. The label includes the brand name Norditropin and the strength 15 mg/1.5 mL, with Novo Nordisk as the labeler. The label features usage information and regulatory details in a clear layout.*

FDA Label Image

W5 (Export 03)

Norditropin 10 mg/1.5 mL injection solution carton for subcutaneous use. The label displays the proprietary name, somatropin as the active ingredient, and strength of 10 mg/1.5 mL. It includes a caution to protect from light and keep refrigerated, with storage instructions. Manufacturer is Novo Nordisk.*

FDA Label Image

W5 (Export 04)

Norditropin somatropin injection, solution for subcutaneous use is shown in a clear vial with a silver cap and a color-coded label indicating the strength. The vial label includes the Novo Nordisk branding and dosage details. The image depicts a 30 mg/3 mL strength vial from Novo Nordisk.*

FDA Label Image

Export 05

Norditropin 10 mg/1.5 mL injection solution for subcutaneous use shown in a carton. The label displays the proprietary name Norditropin and the active ingredient somatropin, along with the strength of 10 mg per 1.5 mL. The product is labeled by Novo Nordisk and contains a prefilled pen device for administration.*

FDA Label Image

Export 06

Norditropin somatropin injection, solution for subcutaneous use. The visible vial shows a 30 mg per 3 mL strength, manufactured by Novo Nordisk. The vial includes dosage markings and a green cap with a gray stopper, contained within a transparent glass container.*

FDA Label Image

Export 07

Norditropin packaging label showing multiple cartons for somatropin injection, solution for subcutaneous use. Available strengths include 10 mg/1.5 mL, 15 mg/1.5 mL, 30 mg/3 mL, and 5 mg/1.5 mL. The labeler is Novo Nordisk. The label features dosage and usage information by carton color coding.*

FDA Label Image

5mg Ifu (Image 01)

Norditropin 10 mg/1.5 mL injection solution carton for subcutaneous use. The packaging shows the proprietary name Norditropin prominently, labeled as somatropin injection solution. The labeler is Novo Nordisk. The box design includes a white and green color scheme with dosage strength and volume indicated as 10 mg per 1.5 mL.*

FDA Label Image

10mg Ifu (Image 02)

Norditropin somatropin injection, solution, 30 mg/3 mL, in a glass vial with a gray and blue cap. The vial label displays the product name, strength, dosage form, and confirms subcutaneous administration, manufactured by Novo Nordisk.*

FDA Label Image

Pen Cap (Image 03)

Norditropin FlexPro somatropin injection pen with a visible dosage strength of 15 mg/1.5 mL. The device is a subcutaneous injection solution, designed in green and blue colors, labeled by Novo Nordisk. The image includes instructions for use text and the Novo Nordisk logo.*

FDA Label Image

Needle (example) (Image 04)

An illustrated diagram of the Norditropin FlexPro Pen showing labeled parts including the pen window, pen scale, dose counter, dose pointer, dose selector, and dose button, along with the pen cap. Below, separate images depict parts of a needle assembly: outer needle cap, inner needle cap, needle, and paper tab. The FlexPro Pen label shows Norditropin 15 mg/1.5 mL strength.*

FDA Label Image

15mg Ifu (Image 05)

Norditropin 30 mg/3 mL injection solution carton, labeled for subcutaneous use. The packaging is primarily yellow and white with the Novo Nordisk logo at the top. The product name Norditropin and the strength 30 mg/3 mL are clearly visible along with the labeler Novo Nordisk. This is a human prescription drug solution for injection.*

FDA Label Image

Step 1 (Fig. A)

An instructional illustration showing a green Norditropin injection pen next to a medicine vial and a separate needle. The pen is labeled for subcutaneous injection, representing the product Norditropin (somatropin) in injection solution form by Novo Nordisk.*

FDA Label Image

Step 1 (Fig. B)

Instructional diagram depicting a close-up of a hand holding a Norditropin injection pen. The pen tip is shown with the cap being removed or attached, illustrating part of the medication preparation process for the subcutaneous injection of somatropin.*

FDA Label Image

Step 1 (Fig. C)

An instructional illustration showing components of the PenMate device for Norditropin somatropin injection. It highlights the charm slot, PenMate cap, PenMate window, and insertion button on the injection device used for subcutaneous administration.*

FDA Label Image

Step 1 (Fig. D)

Illustration of the Norditropin FlexPro 5 mg, 10 mg, or 15 mg injection pen showing labeled parts including pen cap, front stopper, growth hormone scale, needle thread, pen window, display window, dose pointer, dose selector, and dose button.*

FDA Label Image

Step 2 (Fig. E)

An illustration of a blue pen case for Norditropin injection solution. The case is shown open, designed to hold and protect the pen for subcutaneous injection of somatropin. Text below the image indicates that the pen and needles are not included in the case.*

FDA Label Image

Image 100

FDA Label Image

Image 101

Norditropin FlexPro 10 mg/1.5 mL injection pen for subcutaneous use containing somatropin. The image shows a blue and teal injector pen with a label indicating the strength and product name. The labeler is Novo Nordisk, whose logo appears in the bottom right corner of the image.*

FDA Label Image

Image 102

Illustration of the Norditropin FlexPro Pen injection device labeled with parts including the pen cap, pen window, pen scale, dose counter, dose pointer, dose selector, and dose button. Also shown are example needle components: outer needle cap, inner needle cap, needle, and paper tab. The pen label indicates Norditropin (somatropin injection) 10 mg/1.5 mL prefilled pen by Novo Nordisk.*

FDA Label Image

Image 103

An instructional illustration showing a Norditropin injection pen with a needle attached, positioned next to a vial or container. This diagram likely depicts components used for subcutaneous injection delivery of Norditropin (somatropin) injection solution.*

FDA Label Image

Image 104

An instructional illustration showing a close-up of a hand holding a Norditropin injection pen with the needle cap attached, demonstrating part of the subcutaneous injection preparation process.*

FDA Label Image

Image 105

An instructional illustration showing a hand holding a needle cap with an arrow indicating the motion to remove or lift the cap from a needle or injection device. The drawing is outlined in blue and white, emphasizing the removal action typically associated with preparing an injection.*

FDA Label Image

Image 106

An instructional illustration showing a hand holding a syringe or injection device. The image demonstrates the motion of sliding a component, indicated by an arrow pointing to the left, suggesting a step in preparation or assembly of the injection device for Norditropin solution.*

FDA Label Image

Image 107

Instructional illustration showing a hand holding the cap of a needle, removing it by pulling away from an injection device. The image is part of usage directions for Norditropin somatropin injection, solution.*

FDA Label Image

Image 108

Norditropin 30 mg/3 mL injection solution carton for subcutaneous use. The label shows Novo Nordisk as the manufacturer. The box is mainly white with blue and green accents and includes the Norditropin brand name prominently at the top. The strength 30 mg/3 mL is displayed near the bottom with dosage form and usage instructions in smaller text.*

FDA Label Image

Image 109

An instructional illustration showing hands holding a Norditropin injection pen, demonstrating the action of turning or adjusting the dose dial, indicating a step in the subcutaneous injection process for somatropin solution.*

FDA Label Image

Step 2 Fig. F (Image 11)

An instructional illustration showing a close-up of hands removing a protective cap from the needle of a subcutaneous injection device. An arrow indicates the direction of cap removal, demonstrating how to prepare the injection for use.*

FDA Label Image

Image 110

An illustration showing a close-up view of a dosing dial on a Norditropin injection pen, indicating a dose setting of 0.1 mg. The dial is marked with numerical values, used for subcutaneous administration of somatropin solution by Novo Nordisk.*

FDA Label Image

Image 111

Norditropin injection, solution for subcutaneous use, available in 15 mg/1.5 mL strength. The packaging is a white and blue box showing the brand name Norditropin prominently, with the active ingredient somatropin listed. The labeler is Novo Nordisk. The package specifies that this is a human prescription drug.*

FDA Label Image

Image 112

Instructional illustration showing a hand holding an injection pen with the thumb pushing up on the pen's green dose button, indicating the step to set or prepare the dose for subcutaneous injection.*

FDA Label Image

Image 113

An instructional illustration depicting a close-up view of the tip of a medical injection pen, showing a small droplet at the needle end, indicating preparation for subcutaneous injection, related to Norditropin somatropin injection, solution.*

FDA Label Image

Image 114

Instructional illustration showing how to peel a label from a Norditropin injection pen. The image depicts two hands holding the pen, with an arrow indicating the peeling direction of the label revealing the dosage strength (10 mg/mL) on the label.*

FDA Label Image

Image 115

An instructional illustration showing close-up views of a dosage selector on a drug delivery device. The first image example displays a dose selection of 2.95 mg, and the second example shows a dose selection of 0.7 mg, indicating adjustable dosage increments for a subcutaneous injection.*

FDA Label Image

Image 116

An instructional illustration showing a hand peeling a protective seal or cover labeled with a dosage strength from a small vial or cartridge. The step is framed within a blue outline and includes an arrow indicating the direction to remove the seal.*

FDA Label Image

Image 117

An instructional illustration showing a hand holding a pen-like injection device with the thumb positioned on the top button. A downward arrow indicates pressing the button to deliver the injection, implying subcutaneous administration technique for Norditropin injection solution.*

FDA Label Image

Image 118

An instructional illustration showing a hand holding a Norditropin injection pen, positioned for subcutaneous injection. An inset shows the dose window of the device, indicating a selectable dose in milligrams. A downward arrow indicates the direction of injection into the skin.*

FDA Label Image

Image 119

An instructional illustration showing a hand holding a syringe injecting into the inner forearm. A speech bubble instructs to count slowly from 1 to 6 during the injection process.*

FDA Label Image

Step 2 (Fig. G)

An instructional diagram showing a hand holding a device, with an arrow indicating the direction to slide or pull a component, likely related to preparing or administering the Norditropin injection solution.*

FDA Label Image

Image 120

An instructional illustration showing a subcutaneous injection with a syringe or pen needle being inserted into the skin. The image includes an upward arrow above the needle, indicating a step in the injection process for the Norditropin somatropin injection solution.*

FDA Label Image

Image 121

An instructional illustration showing a close-up of a hand preparing an injection pen. The image depicts a thumb pressing or adjusting the orange dose dial or button of the device, with an arrow indicating downward movement. This suggests a step in the preparation or administration of an injectable medication, likely Norditropin somatropin injection.*

FDA Label Image

Image 122

Norditropin 10 mg/1.5 mL injection solution label for subcutaneous use. The label shows Novo Nordisk as the labeler. The packaging is primarily blue and white with dosage strength and route clearly visible. Product information is printed in English with dosage details and manufacturer branding.*

FDA Label Image

Image 123

Norditropin 30 mg/3 mL injection solution label for subcutaneous use. The label features the brand name Norditropin prominently at the top with Novo Nordisk as the labeler. The label is primarily white and teal-green with product strength and dosage form information clearly displayed. The vial size is indicated as 3 mL.*

FDA Label Image

Image 124

Norditropin 15 mg/1.5 mL injection solution in a multi-dose pen carton by Novo Nordisk. The packaging shows the product name and strength on a light green background with additional product information, including somatropin as the active ingredient and instructions for subcutaneous use. The carton design includes the Novo Nordisk logo in the top left corner.*

FDA Label Image

Image 125

An instructional illustration showing a hand peeling off the protective cap from the top of a pen-type injection device, likely representing administration preparation for Norditropin injection solution by subcutaneous route.*

FDA Label Image

Image 126

Norditropin somatropin injection, solution in a 1.5 mL cartridge at 5 mg strength. The label shows Novo Nordisk as the manufacturer and includes dosing and handling instructions on the cartridge container.*

FDA Label Image

Image 127

Norditropin 5 mg/1.5 mL subcutaneous injection solution carton. The front panel includes the brand name Norditropin with a green circle design. The label indicates the dosage strength of 5 mg/1.5 mL and administration method as a subcutaneous injection. The product is labeled for prescription use and is manufactured by Novo Nordisk. The carton also features a barcode and various regulatory information.*

FDA Label Image

Image 128

Norditropin 30 mg/3 mL injection solution for subcutaneous use by Novo Nordisk. The image shows a clear vial with a green cap and a label indicating the product name, strength, and administration route. The vial contains a liquid solution for injection.*

FDA Label Image

Image 129

FDA Label Image

Step 2 (Fig. H)

An instructional illustration showing a hand holding a pen-like device with a cap being removed by pulling it away, indicated by an arrow. This is part of the usage instructions for the Norditropin injection solution delivery device.*

FDA Label Image

Image 130

An instructional diagram showing a vial with its cap being removed by lifting upwards and away from the vial. The vial is shown with a screw-on or snap-off cap, indicated by an arrow demonstrating the removal action.*

FDA Label Image

Image 131

An instructional illustration showing a hand holding a Norditropin injection device, with an arrow indicating a step in the use process, likely related to preparing or administering the somatropin subcutaneous injection solution.*

FDA Label Image

Image 132

Norditropin 10 mg/1.5 mL injection solution in a multi-dose cartridge for subcutaneous administration. The label displays the proprietary name Norditropin prominently in blue above a blue background, with the dosage strength 10 mg/1.5 mL and somatropin listed. The label includes standard information about the volume and administration route, with Novo Nordisk identified as the labeler.*

FDA Label Image

Image 133

Norditropin 10 mg/1.5 mL injection solution for subcutaneous use by Novo Nordisk, shown in a glass cartridge with printed labels detailing strength, dosing volume, and storage information. The packaging highlights the product name, dosage form, and concentration clearly on the cartridge.*

FDA Label Image

Image 134

Norditropin 10 mg/1.5 mL injection, solution in a subcutaneous pre-filled pen cartridge. The package shows a white label with blue and black text, indicating somatropin as the active ingredient. The label includes Novo Nordisk as the labeler and has detailed prescription information visible on the cartridge.*

FDA Label Image

Image 135

An instructional illustration showing a hand gripping a cylindrical device labeled with a 'G'. The image indicates an upward arrow, suggesting a step to pull or lift part of the device vertically. No text or branding is visible on the device in the image.*

FDA Label Image

Image 136

An instructional illustration showing the top part of a medical injection pen with a needle attached. The image highlights the needle guard and the needle tip, typically used for subcutaneous injection of Norditropin (somatropin) injection solution.*

FDA Label Image

Image 137

Instructional illustration showing hands preparing an injection device, demonstrating the initial step of removing a protective cap from a medication pen or injector for subcutaneous administration.*

FDA Label Image

Image 138

An instructional illustration showing the dosage selection window of a Norditropin injection pen set to 2.4 mg. The image demonstrates how the dose appears on the pen's digital display, with accompanying text labeling it as an example dose selected.*

FDA Label Image

Image 139

An instructional diagram showing a syringe scale with dosage markings at 0.6 mg and 0.8 mg. The example highlights a selected dosage of 0.7 mg, demonstrating dose setting on the injection device for Norditropin (somatropin) injection solution.*

FDA Label Image

Step 3 (Fig. I)

An instructional diagram showing two hands adjusting the dosage setting on a Norditropin injection pen. The image highlights a dose window indicating a specific milligram amount, demonstrating how to select or confirm the dose before subcutaneous injection.*

FDA Label Image

Image 140

An instructional illustration showing how to twist a blue cap off a Norditropin somatropin injection pen for subcutaneous use. The image depicts two hands holding the pen with a curved arrow indicating the removal direction of the cap.*

FDA Label Image

Image 141

An instructional illustration showing a hand holding an injection device positioned to administer a subcutaneous injection into the skin of an arm. A downward arrow indicates the downward motion for injection, consistent with subcutaneous injection guidance.*

FDA Label Image

Image 142

Norditropin injection, solution, subcutaneous use, available in strengths including 10 mg/1.5 mL, 15 mg/1.5 mL, 30 mg/3 mL, and 5 mg/1.5 mL. The label features the Novo Nordisk logo and branding, with somatropin as the active ingredient.*

FDA Label Image

Image 143

An instructional illustration showing a hand holding an injection device with a downward arrow indicating the direction of injection or use. The injection device is labeled with a dosage indicator set at "03 mg". The background and border have a blue theme.*

FDA Label Image

Image 144

An instructional illustration showing a person injecting medication subcutaneously into the forearm using a syringe. The image includes a speech bubble with the instruction 'Count slowly: 1-2-3-4-5-6' to guide the injection pace.*

FDA Label Image

Image 145

Norditropin injection, solution for subcutaneous use, available in 30 mg/3 mL strength. The label includes Novo Nordisk as the manufacturer. The vial is clear glass with a red cap and displays product name, strength, and relevant labeling information for prescription use.*

FDA Label Image

Image 146

Illustration showing a subcutaneous injection technique where a syringe needle is being inserted beneath the skin surface, indicated by an upward arrow. The syringe and needle are depicted in close-up, emphasizing the administration step for a solution injection like Norditropin somatropin.*

FDA Label Image

Image 147

Instructional illustration showing a hand peeling back a protective cap from the top of a vial or pen device, indicated by an arrow. This image demonstrates preparation steps likely associated with the Norditropin injection solution for subcutaneous use.*

FDA Label Image

Image 148

An instructional illustration showing the removal of a vial cap. The image depicts a vial with a cap and an arrow indicating the action of lifting or twisting off the cap. This likely relates to preparation steps for an injection solution.*

FDA Label Image

Image 149

An illustration showing hands preparing a Norditropin injection device. One hand holds the device, while the other applies downward pressure on a purple colored component, indicating how to activate or prepare the injection for subcutaneous administration.*

FDA Label Image

Step 3 (Fig. J)

Illustration showing a close-up of the dosage window on an injection pen for Norditropin (somatropin) solution. The dial displays a dosage setting between 0.2 and 0 mg, indicating the pen's adjustable dose feature for subcutaneous injection.*

FDA Label Image

Image 150

Norditropin somatropin 10 mg/1.5 mL injection solution in a subcutaneous dosage form. The product label shows the Novo Nordisk labeler with the brand name prominently displayed on a multicolor background. The label contains product strength and dosage information along with a barcode and lot number area.*

FDA Label Image

Image 151

An instructional illustration showing a close-up of a Norditropin injection pen with a pen scale and an example dosage marking of approximately 10 mg left in the pen. The image highlights how to read the remaining dose on the pen for subcutaneous injection.*

FDA Label Image

Image 152

An instructional illustration showing hands holding a Norditropin injection pen with a close-up of the dose window displaying an example dose of 3.8 mg left. The image visually explains how to read the remaining dose amount on the dose counter of the injection pen.*

FDA Label Image

Image 153

Norditropin 10 mg/1.5 mL injection solution label for subcutaneous use. The label is primarily blue with product and labeler information. It includes Novo Nordisk as the labeler and highlights the active ingredient somatropin. The label features dosage strength and volume details.*

FDA Label Image

Image 154

Norditropin somatropin injection, solution in a 10 mg/1.5 mL multi-dose cartridge. The labeling shows the Novo Nordisk logo and includes dosage form and concentration details. The package is primarily white with blue and pink accents and contains four cartridges.*

FDA Label Image

Image 155

Norditropin 10 mg/1.5 mL injection solution carton for subcutaneous use. The rectangular box shows the brand name Norditropin prominently in blue and green font on a white background. The label indicates the product contains somatropin, a human prescription drug, and the labeler is Novo Nordisk.*

FDA Label Image

Image 156

Norditropin somatropin injection, solution in a 3 mL vial with a concentration of 30 mg/3 mL. The label includes dosing instructions and patient information in blue and black text on a white background. Manufactured by Novo Nordisk.*

FDA Label Image

Image 157

Norditropin 10 mg/1.5 mL injection solution carton for subcutaneous administration. The label displays the product name, somatropin as the active ingredient, and the strength 10 mg per 1.5 mL. The packaging is white with pink and purple design elements and includes Novo Nordisk as the labeler.*

FDA Label Image

Image 158

Norditropin (somatropin) injection, solution for subcutaneous use, available in a 10 mg/1.5 mL cartridge. The packaging shows a white and blue box with the Novo Nordisk logo and name. The product is for human prescription use.*

FDA Label Image

Image 159

Norditropin 10 mg/1.5 mL injection solution in a subcutaneous route, presented in a clear glass vial with a blue and white label bearing the Novo Nordisk logo. The vial contains a liquid drug formulation labeled somatropin, intended for human prescription use.*

FDA Label Image

Step 3 (Fig K)

An instructional illustration showing a hand holding the Norditropin injection device, with a directional arrow pointing upward, indicating a step to remove or adjust a part of the device. The image is related to the preparation or administration of the Norditropin subcutaneous injection.*

FDA Label Image

Image 160

Norditropin injection, solution, subcutaneous, containing somatropin. Available strengths shown include 5 mg/1.5 mL, 10 mg/1.5 mL, 15 mg/1.5 mL, and 30 mg/3 mL. The product is distributed by Novo Nordisk. The image shows multiple packaging boxes in various colors corresponding to different strengths.*

FDA Label Image

Image 161

Norditropin injection, solution, somatropin 5 mg/1.5 mL in a prefilled pen cartridge. The packaging shows the Novo Nordisk labeler name and specifies the 5 mg dosage strength for subcutaneous use.*

FDA Label Image

Image 162

Norditropin 10 mg/1.5 mL injection solution for subcutaneous use in a prefilled pen cartridge. The white and orange label displays the proprietary name Norditropin, the strength (10 mg/1.5 mL), and the labeler Novo Nordisk on a clear cartridge with visible solution inside.*

FDA Label Image

Image 163

Norditropin 10 mg/1.5 mL injection solution in a clear glass cartridge with liquid visible inside. The cartridge includes a white label displaying the brand name Norditropin and dosage strength. The medication is intended for subcutaneous use and labeled by Novo Nordisk.*

FDA Label Image

Image 164

Norditropin 10 mg/1.5 mL injection solution in a 3 mL cartridge for subcutaneous use. The label shows the proprietary name, somatropin as the active ingredient, strength, dosage form, and is labeled by Novo Nordisk. The cartridge packaging is visible with the product and manufacturer information.*

FDA Label Image

Image 165

Norditropin 10 mg/1.5 mL injection solution carton for subcutaneous use. The white and blue rectangular carton displays the product name Norditropin prominently with the Novo Nordisk logo and branding. It includes dosage strength and volume information and states the product as a human prescription drug.*

FDA Label Image

Image 166

Norditropin somatropin injection, solution in a 10 mg/1.5 mL vial, labeled for subcutaneous use. The vial features a clear glass container with a blue plastic cap and a label showing the product name, active ingredient, concentration, and manufacturer, Novo Nordisk.*

FDA Label Image

Image 167

FDA Label Image

Image 168

Norditropin 15 mg/1.5 mL injection solution for subcutaneous use, displayed in a clear glass vial with a silver metal cap and a red flip-off seal. The vial label shows the brand name, strength, dosage form, and the manufacturer Novo Nordisk.*

FDA Label Image

Image 169

Norditropin 10 mg/1.5 mL injection solution in a subcutaneous delivery cartridge. The label is white with orange and yellow highlights and features the Novo Nordisk logo and branding. The cartridge package indicates the product name, strength, and labeler Novo Nordisk.*

FDA Label Image

Step 3 (Fig. L)

An instructional illustration showing the tip of an injection pen with a droplet at the needle end. The image is associated with Norditropin (somatropin) injection, solution for subcutaneous use, by Novo Nordisk.*

FDA Label Image

Image 170

Norditropin 10 mg/1.5 mL injection, solution in a subcutaneous delivery pen cartridge. The label shows dosage strength (10 mg per 1.5 mL), product name, and Novo Nordisk as the labeler. The packaging is white with purple and light blue accents and includes usage information and storage instructions on the label.*

FDA Label Image

Image 171

Norditropin 10 mg/1.5 mL injection, solution in a 1.5 mL cartridge for subcutaneous use. The label shows the Novo Nordisk logo with a blue and white color scheme, and details including the proprietary name, nonproprietary name somatropin, strength, and dosage form. The cartridge label is designed for single-patient use.*

FDA Label Image

Image 172

Norditropin 10 mg/1.5 mL injection solution in a subcutaneous formulation. The image shows the clear type of packaging label with Novo Nordisk as the labeler. The label features usage and dosage information in gray text on a white and gray background, with branding elements on the side.*

FDA Label Image

Image 173

The image shows the carton packaging for Norditropin 5 mg/1.5 mL injection, solution for subcutaneous use. The label indicates the product contains somatropin and is manufactured by Novo Nordisk. The carton features branding with green and dark blue colors and states 'Norditropin SimpleXx' prominently on the front.*

FDA Label Image

Image 174

Norditropin somatropin 10 mg/1.5 mL injection, solution for subcutaneous use in a cartridge form. The label shows the Novo Nordisk logo and includes dosage strength information along with the proprietary and generic names. This product is marketed by Novo Nordisk.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.